Is newer better? Not according to Consumer Reports which, based on cost and effectiveness criteria, picked three generic drugs over FDA approved drugs for FM patients. Check out which drugs they favored and download the report at Consumer Reports Recommends Generics...
With a UK trial for Rituximab at least temporarily in doubt, let’s turn the focus to Ampligen – a drug that is potentially one trial away from being approved for ME/CFS. Ampligen is still the only drug that’s been able to move the needle on exercise...
She’s had chronic fatigue syndrome (ME/CFS) for twenty-eight years and has left no stone unturned in her attempts to get well. She’s traveled widely and seen some of the best ME/CFS doctors in the world. Despite being connected to the hilt in the ME/CFS,...
The National Pain Report recently released the results of its fibromyalgia survey examining treatment effectiveness and other questions. Almost 1,500 people participated. (Please note that the percentages in this table are different from those in the National Pain...
After the FDA nixed its approval for Ampligen and saddled its producer, Hemispherx Biopharma, with paying for a large new trial, it looked like Ampligen was dead and gone. Francis Collin’s promise to increase ME/CFS funding, however, caused a seismic shift in...
A fibromyalgia doctor just gave the thumbs up to ketamine. So did the past director of the National Institute of Mental Health. They both think ketamine or rather drugs based on it could be the cat’s meow for pain and depression. But ketamine also recently...
Keep the information flowing! Support Health Rising during our end of the year fundraising drive. Click here for more.
Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News
Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.